Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Scios Inc

In 2001, Scios Inc. caught international attention with the successful U.S. launch of NATRECOR® (nesiritide), the first new approved treatment for acute heart failure in more than a decade. To date, NATRECOR® has been the best selling IV cardiovascular drug ever brought to market. In February 2003, Scios made headlines again when it became a member of the Johnson & Johnson Family of Companies, the world's most comprehensive and broadly based manufacturer of health care products.


Contact Details:
6500 Paseo Padre Parkway
Fremont
California
94555
United States of America
Tel:(510) 248-2500
Fax:(510) 248-2389
Email:
WWW:

www.sciosinc.com/




Loading...

Recent Publications by Scios Inc:

Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
BACKGROUND: The myocardium secretes B-type natriuretic peptide (BNP) in...
11th November, 2009
Scios Inc., Mountain View, CA, USA. Circ Heart Fail. 2008 Nov;1(4):258-64. Epub 2008 Oct 14.
DOI Direct Link
The heart failure frequent flyer: an urban legend.
BACKGROUND: The myocardium secretes B-type natriuretic peptide (BNP) in...
16th October, 2009
Medical Affairs, Scios Clin Cardiol. 2009 Feb;32(2):67-8.
DOI Direct Link
Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.
BACKGROUND: TGFbeta has emerged as an attractive target for the...
30th June, 2009
Biomarker R&D, J Transl Med. 2009 Feb 3;7:12.
DOI Direct Link
p38alpha-selective MAP kinase inhibitor reduces tumor growth in mouse xenograft models of multiple myeloma.
Multiple myeloma (MM) is a clonal plasma cell malignancy, which is...
4th March, 2009
Scios Inc, Anticancer Res. 2008 Nov-Dec;28(6A):3827-33.
Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment.
Myelodysplastic syndromes (MDS) are common causes of ineffective...
30th December, 2008
Scios Inc, Fremont, CA, USA. Leuk Lymphoma. 2008 Oct;49(10):1963-75.
DOI Direct Link

View more Scios Inc research publications.

Press Releases on Scios Inc:

BioPortfolio Logo
United States Joins Suits Against Scios and Johnson & Johnson 19th February, 2009 U.S. Department of Justice
Pharmaceutical Companies Allegedly Marketed the Drug Natrecor for a Use Not Approved By the Food and Drug Administration WASHINGTON, Feb. 19 /PRNewswire-USNewswire/ -- The United States has
Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure 16th October, 2008 Intrinsic Bioprobes Inc.
TEMPE, Ariz., Oct. 16 /PRNewswire/ -- A team of researchers from Intrinsic Bioprobes Inc. has reported on a novel quantitative mass spectrometry immunoassay for the detection of bioactive B-type
Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research 9th September, 2008 Intarcia Therapeutics, Inc.
HAYWARD, Calif., Sept. 9 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the appointment of Kenneth Luskey, M.D. to the newly created position of Vice President, Clinical Research

BioNews Results for Scios Inc:

NewCo News
Pharmacy Choice:  Nov 5 2009 3:43PM Matching: scios inc

Scios Inc Patents:

US Patent No.Title
6458923 Modified position (7) bradykinin antagonist peptides
6770741 Brandykinin antagonist peptides
6800455 Secreted factors
6821966 Inhibitors of p38 kinase
6828303 Prolonged delivery of peptides

View more Scios Inc patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 661 times since April 2007, the link to the organisation's website has been followed 80 times

Recent Search Terms used to find this page: scios | Scios Inc | scios | Scios Inc. | SD 282 Scios Inc. | SD 282 Scios Inc. | SD-282 Scios Inc | SD-282 Scios Inc | SD-282 Scios Inc | scios | .

Search for more companies in Fremont

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Scios Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.